Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008728 |
ID: | TCMBANKHE008728 |
植物拉丁名: |
|
功能与主治: | To supplement kidney and secure essence, boost liver and brighten eyes./Liver kidney vacuity, lumbago and limp leg, emission and premature ejaculation, frequent urination, dizziness and tinnitus, clouded flowery vision. |
药用植物名: | 扁茎黄芪 |
药用部位: | seed |
TCM_ID_id: | 4573 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN003909 | 3-o-α-l-rhamnopyranosyl(1→2)-β-d-galacto-pyranosyl(1→2)-6-o-methyl-β-d-glucurono-pyranosyl-soyasapogenol b-22-o-β-d-gluco-pyranoside | C55H90O23 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4CCC5(C(C4(C)CO)CCC6(C5CC=C7C6(CCC8(C7CC(CC8OC9C(C(C(C(O9)CO)O)O)O)(C)C)C)C)C)C)C(=O)OC)O)O)CO)O)O)O)O)O | ||
| TCMBANKIN003978 | comptonine | C37H49NO10 | 667.8 g/mol | CC1=C2C(C(C3(C(CC(C2(C)C)CC1=O)C(=C)C(CC3OC(=O)C)OC(=O)C(C(C4=CC=CC=C4)N(C)C)O)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN011338 | 3-o-α-l-rhamnopyranosyl(1→2)-β-d-galacto-pyranosyl(1→2)-6-o-methyl-β-d-glucurono-pyranosyl-3β,22β,24-trihudroxy-11-oxo-olean-12-ene | C49H78O18 | |||
| TCMBANKIN018248 | complanatuside | 4H-1-Benzopyran-4-one,3-(b-D-glucopyranosyloxy)-2-[4-(b-D-glucopyranosyloxy)phenyl]-5-hydroxy-7-methoxy-; 4CH-024740 | C28H32O16 | 624.54 | COC1=CC(=C2C(=C1)OC(=C(C2=O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC=C(C=C4)OC5C(C(C(C(O5)CO)O)O)O)O |
| TCMBANKIN024908 | 3-o-α-l-rhamnopyranosyl(1→2)-β-d-xylo-pyranosyl(1→2)-6-o-methyl-β-d-glucurono-pyranosyl-3β,22β,24-trihydroxy-11-oxo-olean-12-ene | C48H76O18 | |||
| TCMBANKIN029385 | 10,13- octadecadienoic acid | 10,13-Octadecadienoic acid; 10,13-octadecadienoicacid | C18H32O2 | 280.4 g/mol | CCCCC=CCC=CCCCCCCCCC(=O)O |
| TCMBANKIN032825 | 3-o-α-l-rhamnopyranosyl(1→2)-β-d-xylopy-ranosyl(1→2)-6-o-methyl-β-d-glucuronopy-ranosyl-soyasapogenol b 22-o-β-d-glucopyra-noside | C54H88O22 | CC1C(C(C(C(O1)OC2C(C(COC2OC3C(C(C(OC3OC4CCC5(C(C4(C)CO)CCC6(C5CC=C7C6(CCC8(C7CC(CC8OC9C(C(C(C(O9)CO)O)O)O)(C)C)C)C)C)C)C(=O)OC)O)O)O)O)O)O)O | ||
| TCMBANKIN038599 | Neocryptomerin | 552.5 g/mol | |||
| TCMBANKIN043537 | Rhamnocitrin-3-O-β-D-glucoside | ||||
| TCMBANKIN048275 | myricoside | C34H44O19 | 756.7 g/mol | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)OC5C(C(CO5)(CO)O)O)O | |
| TCMBANKIN050308 | astragaloside viii methylester | C48H78O17 | CC1C(C(C(C(O1)OC2C(C(COC2OC3C(C(C(OC3OC4CCC5(C(C4(C)CO)CCC6(C5CC=C7C6(CCC8(C7CC(CC8O)(C)C)C)C)C)C)C(=O)OC)O)O)O)O)O)O)O | ||
| TCMBANKIN059053 | neocomplanoside | [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxyoxan-2-yl]methyl acetate; Neocomplanoside; 4H-1-Benzopyran-4-one, 3-((6-O-acetyl-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-; DTXSID60154013; 123442-25-1; AC1NUPAO; acetic acid [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxo-3-chromenyl]oxy]-2-tetrahydropyranyl]methyl ester; [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxo-chromen-3-yl]oxy-tetrahydropyran-2-yl]methyl acetate; [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxo-chromen-3-yl]oxy-oxan-2-yl]methyl ethanoate; 123442-25-1; acetic acid [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-4-keto-7-methoxy-chromen-3-yl]oxy-tetrahydropyran-2-yl]methyl ester | C24H24O12 | 504.44 | CC(=O)OCC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)OC)C4=CC=C(C=C4)O)O)O)O |
| TCMBANKIN060905 | Ricineic acid | C18H32O2 | 280.45 | CCCCCCC=CC=CCCCCCCCC(=O)O | |
| TCMBANKIN061455 | 4H-1-Benzopyran-4-one, 2-(3-(beta-D-glucopyranosyloxy)-4-hydroxy-5-methoxyphenyl)-3,5,7-trihydroxy- | 3,5,7-trihydroxy-2-[4-hydroxy-3-methoxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one; 3,5,7-trihydroxy-2-[4-hydroxy-3-methoxy-5-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]-4-chromenone; 3,5,7-trihydroxy-2-[4-hydroxy-3-methoxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]chromen-4-one; 123442-26-2; 3,5,7-trihydroxy-2-[4-hydroxy-3-methoxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]chromen-4-one; 3,5,7-trihydroxy-2-[4-hydroxy-3-methoxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-phenyl]chromone; myricomplanoside | C22H22O13 | 494.4 | COC1=C(C(=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab